Categories AlphaGraphs, Earnings, LATEST

Delta Air Lines’ Q2 results beat market estimates

Delta Air Lines (NYSE: DAL) reported better-than-expected revenue and earnings for the second quarter of 2019, allowing shares to climb 2.2% in premarket hours on Thursday. The consensus estimate was for earnings of $2.24 per share on revenue of $12.4 billion.

Total operating revenue of $12.5 billion was up 6.5% from the same period last year. On an adjusted basis, revenues grew 8.7%, helped by a 10% increase in premium product ticket revenue and double-digit percentage increases in loyalty and third-party maintenance revenue.  

Delta Air Lines posts better-than-expected June quarter results

On a GAAP basis, net income grew 39% to $1.4 billion and EPS grew 48% to $2.21. Adjusted EPS grew 32% to $2.35.  

Total revenue per available seat mile (TRASM) grew 1.6% year-over-year on a GAAP basis and 3.8% on an adjusted basis. Consolidated unit cost (CASM) was down 1.5% on a GAAP basis and up 1.4% on an adjusted basis.

During the quarter, Delta saw revenue increases across all its geographic regions helped mainly by higher passenger unit revenue and capacity.

For the third quarter of 2019, Delta expects EPS to come in the range of $2.10-2.40. Adjusted TRASM is expected to grow 1.5-3.5% year-over-year while CASM-Ex is projected to rise 1-2%. System capacity is expected to be up around 4% from the same period last year.   

Based on the strong first half performance, the company raised its full-year 2019 EPS guidance to a range of $6.75-7.25.

Delta increased its quarterly dividend by 15% to $0.4025 per share. The dividend is payable on August 15, 2019 to shareholders of record on July 25, 2019.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Comments

  1. Pingback: fox888

Comments are closed.

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top